Report cover image

Novel Oral AntiCoagulants (NOAC) Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 130 Pages
SKU # APRC20261884

Description

Summary

According to APO Research, the global Novel Oral AntiCoagulants (NOAC) market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Novel Oral AntiCoagulants (NOAC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Novel Oral AntiCoagulants (NOAC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Novel Oral AntiCoagulants (NOAC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Novel Oral AntiCoagulants (NOAC) include Armatheon, Aspen, Boehringer Ingelheim, Bristol-Myers Squibb, Cellceutix, Cosmo Pharmaceuticals, CSL Behring, Daiichi Sankyo and Marathon Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Novel Oral AntiCoagulants (NOAC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Oral AntiCoagulants (NOAC).

The report will help the Novel Oral AntiCoagulants (NOAC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.



The Novel Oral AntiCoagulants (NOAC) market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Novel Oral AntiCoagulants (NOAC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Novel Oral AntiCoagulants (NOAC) Segment by Company

Armatheon
Aspen
Boehringer Ingelheim
Bristol-Myers Squibb
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Daiichi Sankyo
Marathon Pharmaceuticals
Ockham Biotech
Perosphere
AstraZeneca
Bayer
GSK
Johnson & Johnson
Sanofi
Eisai
Novel Oral AntiCoagulants (NOAC) Segment by Type

Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Novel Oral AntiCoagulants (NOAC) Segment by Application

Hemodialysis
Deep Vein Thrombosis (DVT)
Acute Coronary Syndrome
Pulmonary Embolism
Others
Novel Oral AntiCoagulants (NOAC) Segment by Region


North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Novel Oral AntiCoagulants (NOAC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Novel Oral AntiCoagulants (NOAC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Novel Oral AntiCoagulants (NOAC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Novel Oral AntiCoagulants (NOAC) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Novel Oral AntiCoagulants (NOAC) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Novel Oral AntiCoagulants (NOAC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

130 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Novel Oral AntiCoagulants (NOAC) Market Size (2020-2031)
2.2.2 Global Novel Oral AntiCoagulants (NOAC) Sales (2020-2031)
2.2.3 Global Novel Oral AntiCoagulants (NOAC) Market Average Price (2020-2031)
2.3 Novel Oral AntiCoagulants (NOAC) by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Direct Thrombin Inhibitors
2.3.3 Direct Factor Xa Inhibitors
2.4 Novel Oral AntiCoagulants (NOAC) by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hemodialysis
2.4.3 Deep Vein Thrombosis (DVT)
2.4.4 Acute Coronary Syndrome
2.4.5 Pulmonary Embolism
2.4.6 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Novel Oral AntiCoagulants (NOAC) Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Novel Oral AntiCoagulants (NOAC) Sales (W Units) of Manufacturers (2020-2025)
3.3 Global Novel Oral AntiCoagulants (NOAC) Revenue of Manufacturers (2020-2025)
3.4 Global Novel Oral AntiCoagulants (NOAC) Average Price by Manufacturers (2020-2025)
3.5 Global Novel Oral AntiCoagulants (NOAC) Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Novel Oral AntiCoagulants (NOAC), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Novel Oral AntiCoagulants (NOAC), Product Type & Application
3.8 Global Manufacturers of Novel Oral AntiCoagulants (NOAC), Established Date
3.9 Global Novel Oral AntiCoagulants (NOAC) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Armatheon
4.1.1 Armatheon Company Information
4.1.2 Armatheon Business Overview
4.1.3 Armatheon Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Armatheon Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.1.5 Armatheon Recent Developments
4.2 Aspen
4.2.1 Aspen Company Information
4.2.2 Aspen Business Overview
4.2.3 Aspen Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Aspen Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.2.5 Aspen Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Bristol-Myers Squibb
4.4.1 Bristol-Myers Squibb Company Information
4.4.2 Bristol-Myers Squibb Business Overview
4.4.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.4.5 Bristol-Myers Squibb Recent Developments
4.5 Cellceutix
4.5.1 Cellceutix Company Information
4.5.2 Cellceutix Business Overview
4.5.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Cellceutix Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.5.5 Cellceutix Recent Developments
4.6 Cosmo Pharmaceuticals
4.6.1 Cosmo Pharmaceuticals Company Information
4.6.2 Cosmo Pharmaceuticals Business Overview
4.6.3 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.6.5 Cosmo Pharmaceuticals Recent Developments
4.7 CSL Behring
4.7.1 CSL Behring Company Information
4.7.2 CSL Behring Business Overview
4.7.3 CSL Behring Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.7.4 CSL Behring Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.7.5 CSL Behring Recent Developments
4.8 Daiichi Sankyo
4.8.1 Daiichi Sankyo Company Information
4.8.2 Daiichi Sankyo Business Overview
4.8.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.8.5 Daiichi Sankyo Recent Developments
4.9 Marathon Pharmaceuticals
4.9.1 Marathon Pharmaceuticals Company Information
4.9.2 Marathon Pharmaceuticals Business Overview
4.9.3 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.9.5 Marathon Pharmaceuticals Recent Developments
4.10 Ockham Biotech
4.10.1 Ockham Biotech Company Information
4.10.2 Ockham Biotech Business Overview
4.10.3 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.10.5 Ockham Biotech Recent Developments
4.11 Perosphere
4.11.1 Perosphere Company Information
4.11.2 Perosphere Business Overview
4.11.3 Perosphere Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Perosphere Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.11.5 Perosphere Recent Developments
4.12 AstraZeneca
4.12.1 AstraZeneca Company Information
4.12.2 AstraZeneca Business Overview
4.12.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.12.4 AstraZeneca Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.12.5 AstraZeneca Recent Developments
4.13 Bayer
4.13.1 Bayer Company Information
4.13.2 Bayer Business Overview
4.13.3 Bayer Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Bayer Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.13.5 Bayer Recent Developments
4.14 GSK
4.14.1 GSK Company Information
4.14.2 GSK Business Overview
4.14.3 GSK Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.14.4 GSK Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.14.5 GSK Recent Developments
4.15 Johnson & Johnson
4.15.1 Johnson & Johnson Company Information
4.15.2 Johnson & Johnson Business Overview
4.15.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.15.5 Johnson & Johnson Recent Developments
4.16 Sanofi
4.16.1 Sanofi Company Information
4.16.2 Sanofi Business Overview
4.16.3 Sanofi Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Sanofi Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.16.5 Sanofi Recent Developments
4.17 Eisai
4.17.1 Eisai Company Information
4.17.2 Eisai Business Overview
4.17.3 Eisai Novel Oral AntiCoagulants (NOAC) Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Eisai Novel Oral AntiCoagulants (NOAC) Product Portfolio
4.17.5 Eisai Recent Developments
5 Global Novel Oral AntiCoagulants (NOAC) Market Scenario by Region
5.1 Global Novel Oral AntiCoagulants (NOAC) Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Novel Oral AntiCoagulants (NOAC) Sales by Region: 2020-2031
5.2.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Region: 2020-2025
5.2.2 Global Novel Oral AntiCoagulants (NOAC) Sales by Region: 2026-2031
5.3 Global Novel Oral AntiCoagulants (NOAC) Revenue by Region: 2020-2031
5.3.1 Global Novel Oral AntiCoagulants (NOAC) Revenue by Region: 2020-2025
5.3.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Region: 2026-2031
5.4 North America Novel Oral AntiCoagulants (NOAC) Market Facts & Figures by Country
5.4.1 North America Novel Oral AntiCoagulants (NOAC) Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Novel Oral AntiCoagulants (NOAC) Sales by Country (2020-2031)
5.4.3 North America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Novel Oral AntiCoagulants (NOAC) Market Facts & Figures by Country
5.5.1 Europe Novel Oral AntiCoagulants (NOAC) Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Novel Oral AntiCoagulants (NOAC) Sales by Country (2020-2031)
5.5.3 Europe Novel Oral AntiCoagulants (NOAC) Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Novel Oral AntiCoagulants (NOAC) Market Facts & Figures by Country
5.6.1 Asia Pacific Novel Oral AntiCoagulants (NOAC) Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales by Country (2020-2031)
5.6.3 Asia Pacific Novel Oral AntiCoagulants (NOAC) Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Novel Oral AntiCoagulants (NOAC) Market Facts & Figures by Country
5.7.1 South America Novel Oral AntiCoagulants (NOAC) Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Novel Oral AntiCoagulants (NOAC) Sales by Country (2020-2031)
5.7.3 South America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Market Facts & Figures by Country
5.8.1 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales by Country (2020-2031)
5.8.3 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Type (2020-2031)
6.1.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Type (2020-2031) & (W Units)
6.1.2 Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type (2020-2031)
6.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Type (2020-2031)
6.2.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Type (2020-2031)
6.3 Global Novel Oral AntiCoagulants (NOAC) Price by Type (2020-2031)
7 Segment by Application
7.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Application (2020-2031)
7.1.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Application (2020-2031) & (W Units)
7.1.2 Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2020-2031)
7.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Application (2020-2031)
7.2.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Application (2020-2031)
7.3 Global Novel Oral AntiCoagulants (NOAC) Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Novel Oral AntiCoagulants (NOAC) Value Chain Analysis
8.1.1 Novel Oral AntiCoagulants (NOAC) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Novel Oral AntiCoagulants (NOAC) Production Mode & Process
8.2 Novel Oral AntiCoagulants (NOAC) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Novel Oral AntiCoagulants (NOAC) Distributors
8.2.3 Novel Oral AntiCoagulants (NOAC) Customers
9 Global Novel Oral AntiCoagulants (NOAC) Analyzing Market Dynamics
9.1 Novel Oral AntiCoagulants (NOAC) Industry Trends
9.2 Novel Oral AntiCoagulants (NOAC) Industry Drivers
9.3 Novel Oral AntiCoagulants (NOAC) Industry Opportunities and Challenges
9.4 Novel Oral AntiCoagulants (NOAC) Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.